Argentina finished the first phase of tests of a vaccine from Koronavirus

Argentina finished the first phase of tests of own vaccine from Koronavirus, reports National council on scientific and technical researches (CONICET). "The Argentina vaccine of ARVAC Cecilia Grierson is safe and very much immunogenna, follows from the report on clinical tests of the first phase in which 80 healthy people" participated — gives Federal state unitary enterprise RAMI "RIA Novosti" the message. It is noted that a vaccine it is planned to use as a busterny dose. On July 6 the Argentina pharmaceutical company Laboratorios Richmond delivered to SACIF 819 thousand doses of the second component of the Russian vaccine against Koronavirus...